Published on Tuesday October 06, 2020

Smooth Drug Development September 2020 News Release

We were working on the following new projects in September:

Observational trial is being initiated in dermatology

We signed a contract for a bioequivalence study (INN: Paracetamol) with long-term sponsor

Several contracts with international sponsors for PV services were signed


Clinical Department News

Few projects restarted after COVID-19 pandemic.

Enrollment finished in phase III trial in arthrosis

We are preparing for submission in III phase trial in COVID-19

We did a lot of work in II phase trial in COVID-19: contracts with sites are signing, LEC approvals from first site were received, eCRF development was finished and we are preparing protocol amendment